Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Kaye

Showing results (251-260 of 418) with videos related to

Pageof 42
Sort By:
Journal of the American College of Cardiology|July 17, 2007
Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animalsDavid M Kaye, Arthur Preovolos, Tanneale Marshall, et al.
Emergency Medicine Australasia : EMA|August 2, 2022
Epidemiology, outcomes and predictors of mortality in patients transported by ambulance for dyspnoea: A population-based cohort studyJennifer Zhou, Emily Nehme, Luke Dawson, et al.
JACC. Heart Failure|November 3, 2023
Influence of Impaired Conduction on Exercise Hemodynamics in Patients With Preserved Ejection FractionJoseph P Hogarty, Andrea Comella, Shane Nanayakkara, et al.
Hypertension (Dallas, Tex. : 1979)|June 8, 2022
Association Between the Gut Microbiome and Their Metabolites With Human Blood Pressure VariabilityEvany Dinakis, Michael Nakai, Paul Gill, et al.
European Journal of Heart Failure|July 21, 2021
Treating symptoms and reversing remodelling: clinical and echocardiographic 1-year outcomes with percutaneous mitral annuloplasty for mild to moderate secondary mitral regurgitationKlaus K Witte, David M Kaye, Janusz Lipiecki, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 22, 2023
Association of socioeconomic status in the incidence, quality-of-care metrics, and outcomes for patients with cardiogenic shock in a pre-hospital settingJason E Bloom, Nathan Wong, Emily Nehme, et al.
Critical Care Explorations|November 25, 2024
Current Emergency Medical Service Vasoactive Use for the Management of ShockJason E Bloom, Vishal Goel, David Anderson, et al.
Experimental Physiology|October 13, 2018
Serelaxin attenuates renal inflammation and fibrosis in a mouse model of dilated cardiomyopathyBeverly Giam, Po-Yin Chu, Sanjaya Kuruppu, et al.
JACC. Basic to Translational Science|April 1, 2024
Cardiac Substrate Utilization and Relationship to Invasive Exercise Hemodynamic Parameters in HFpEFJohn F O'Sullivan, Mengbo Li, Yen Chin Koay, et al.
Heart (British Cardiac Society)|March 17, 2023
Haemodynamic and metabolic adaptations in coronary microvascular diseaseSamer Noaman, David M Kaye, Shane Nanayakkara, et al.
Pageof 42

Showing results (251-260 of 418) with videos related to

Sort By:
Pageof 42
Journal of the American College of Cardiology|July 17, 2007
Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animalsDavid M Kaye, Arthur Preovolos, Tanneale Marshall, et al.
Emergency Medicine Australasia : EMA|August 2, 2022
Epidemiology, outcomes and predictors of mortality in patients transported by ambulance for dyspnoea: A population-based cohort studyJennifer Zhou, Emily Nehme, Luke Dawson, et al.
JACC. Heart Failure|November 3, 2023
Influence of Impaired Conduction on Exercise Hemodynamics in Patients With Preserved Ejection FractionJoseph P Hogarty, Andrea Comella, Shane Nanayakkara, et al.
Hypertension (Dallas, Tex. : 1979)|June 8, 2022
Association Between the Gut Microbiome and Their Metabolites With Human Blood Pressure VariabilityEvany Dinakis, Michael Nakai, Paul Gill, et al.
European Journal of Heart Failure|July 21, 2021
Treating symptoms and reversing remodelling: clinical and echocardiographic 1-year outcomes with percutaneous mitral annuloplasty for mild to moderate secondary mitral regurgitationKlaus K Witte, David M Kaye, Janusz Lipiecki, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 22, 2023
Association of socioeconomic status in the incidence, quality-of-care metrics, and outcomes for patients with cardiogenic shock in a pre-hospital settingJason E Bloom, Nathan Wong, Emily Nehme, et al.
Critical Care Explorations|November 25, 2024
Current Emergency Medical Service Vasoactive Use for the Management of ShockJason E Bloom, Vishal Goel, David Anderson, et al.
Experimental Physiology|October 13, 2018
Serelaxin attenuates renal inflammation and fibrosis in a mouse model of dilated cardiomyopathyBeverly Giam, Po-Yin Chu, Sanjaya Kuruppu, et al.
JACC. Basic to Translational Science|April 1, 2024
Cardiac Substrate Utilization and Relationship to Invasive Exercise Hemodynamic Parameters in HFpEFJohn F O'Sullivan, Mengbo Li, Yen Chin Koay, et al.
Heart (British Cardiac Society)|March 17, 2023
Haemodynamic and metabolic adaptations in coronary microvascular diseaseSamer Noaman, David M Kaye, Shane Nanayakkara, et al.
Pageof 42